635723-84-1 Usage
Uses
Used in Pharmaceutical Industry:
3-Fluoro-2-(bromomethyl)benzonitrile is used as an intermediate in the production of pharmaceuticals for its unique reactivity and properties. It plays a crucial role in the synthesis of various organic compounds that contribute to the development of new drugs and medications.
Used in Organic Synthesis:
In the field of organic synthesis, 3-Fluoro-2-(bromomethyl)benzonitrile serves as a valuable intermediate. Its reactivity allows for the creation of a wide range of organic compounds, expanding the possibilities for chemical research and development.
Used in Agrochemical Manufacturing:
3-Fluoro-2-(bromomethyl)benzonitrile is also utilized in the manufacturing of agrochemicals. Its properties make it suitable for the production of various specialty chemicals that are essential in agriculture for pest control and crop protection.
Used in Specialty Chemicals Production:
3-Fluoro-2-(bromomethyl)benzonitrile is important in the production of specialty chemicals due to its unique characteristics. Its versatility in chemical reactions contributes to the development of innovative and specialized chemical products for various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 635723-84-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,5,7,2 and 3 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 635723-84:
(8*6)+(7*3)+(6*5)+(5*7)+(4*2)+(3*3)+(2*8)+(1*4)=171
171 % 10 = 1
So 635723-84-1 is a valid CAS Registry Number.
635723-84-1Relevant articles and documents
NRF2 REGULATORS
-
Page/Page column 161, (2017/01/02)
Provided are aryl analogs，pharmaceutical compositions containing them and their use as NRF2 regulators.
QUINAZOLINE LINKED HETEROAROMATIC TRICYCLE DERIVATIVES AS PDE10A ENZYME INHIBITORS
-
Page/Page column 29, (2013/04/13)
This invention is directed to compounds of formula I which are PDE10A enzyme inhibitors, pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier and processes for th
Imidazole derivatives as PDE10A enzyme inhibitors
-
Page/Page column 12, (2012/06/01)
This invention is directed to compounds, which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The pr
